Linear Health Sciences is a medical device company dedicated to developing products for various types of medical tubing based on its proprietary, breakaway safety-valve technology. This platform technology is designed to improve the healthcare experience for patients, caregivers, and healthcare facilities.

The company has made substantial progress toward global patent protections and development of the Orchid Safety Release Valve. There is a total addressable market of more than $5 billion annually for devices made by the company, which was founded by a physician and a business-minded engineer.

Dr. Ryan Dennis, Founder, CEO

ryan-dennis-mdDr. Dennis is a practicing hospitalist residing in Norman, OK. As the original conceptualist of the ORCHID Valve, Dr. Dennis acts as the foundational cornerstone of Linear Health Sciences. By shaping the team’s focus toward maximizing clinical impact, Dr. Dennis drives Linear towards innovation that creates value for patients, providers, and purchasers. Dr. Dennis attended Oklahoma School of Science and Mathematics before graduating with Honors from The University of Chicago. He earned his M.D. and completed a residency in Internal Medicine at the University of Oklahoma Health Sciences Center. Dr. Dennis is currently an MBA candidate at OU’s Price College of Business. With any free time left you can find him spending time with his nurse practitioner wife and little boys, Weston and Jack, or continuing to hone his skills as an avid aviator and instrument-rated private pilot.

Daniel Clark – Co-founder, President | COO

Dan Clark comes to the team with over 8 years of partnering with major medical OEM’s to bring next generation products to market. Born and raised in greater Chicago, Dan is a Purdue University graduate where he earned a Bachelor of Science in Industrial Engineering, with minors in Mechanical Engineering and Management. Dan has a strong history of involvement across all levels of medtech companies to strategically align efforts throughout the development, scaling, regulatory, and commercialization of a product; eventually working as the liaison for medtech OEM leadership on global strategy. Dan’s responsibilities as President | COO of Linear Health Sciences encompass marketing and bizdev efforts, regulatory and technology roadmap management as well as overall growth strategy. As what some would call an over-addicted health nut, Dan’s free time is spent working out or involved in outdoor activities in greater Los Angeles, where he resides with his wife, Amy, a pharmaceutical sales rep, and their young son, Hayden.

Here at Linear Health Sciences our mission is delivering convenience, safety, and satisfaction to every patient connected to a medical line, and every provider supplying them.


At Linear Health Sciences we know that developing a product for clinical use requires consistent feedback to drive the best possible development of a product. Because of this we’ve enlisted the help of several thought leaders in the Vascular Access space for their direction and support – ensuring we bring the most functional and valuable product to market.

Robert B. Dawson
Robert B. Dawson DNP, MSA, APRN, ACNP-BC, VA-BC
Dr. Rob Dawson is a U.S. Navy Nurse Corps Veteran, and has worked in a variety of acute care settings. He has special interest in vascular access quality improvement with a Clinical Microsystems Approach. He has developed systematic approaches to clinical practice to minimize complications, reduce variation in practice, and improve procedure success in peripheral vascular access. He is an internationally recognized author, educator, and speaker on a variety of vascular access topics. Dr. Dawson is a consultant and managing partner for Vascular Access Consultants, LLC (VASC) and still works as a vascular access clinician.
Leigh Ann Bowe-Geddes
Leigh Ann Bowe-GeddesRN, CRNI, VA-BC
Leigh Ann Bowe-Geddes, BSN, RN, CRNI®, VA-BC™ has over 30 years experience in vascular access practice in the ICU, home infusion, and vascular access specialty areas. She is currently a Vascular Access Clinical Consultant, and is a member of the Vascular Access Specialty Team at the University of Louisville Hospital in Louisville, Kentucky.

Ms. Bowe-Geddes is the Past President of the Association for Vascular Access, an international, multi-disciplinary organization dedicated to education and advancement of the specialty practice of vascular access. Ms. Bowe-Geddes is Vascular Access Board Certified (VA-BC) by the Vascular Access Certification Corporation. She is also a member of the Infusion Nurses Society, has been certified as a CRNI since 1991, and has previously served as President of the Bluegrass INS.

Nancy Moureau
Nancy MoureauRN, PhD, BSN, CRNI, CPUI, VA-BC
Nancy L. Moureau is the Chief Executive Officer and Educational Specialist for PICC Excellence, Inc, a company that provides education, consulting and research on vascular access devices. Dr. Moureau is an internationally recognized speaker on Peripherally Inserted Central Catheters and issues of vascular access practice. Her day to day responsibilities include program development, application and maintenance of continuing education “Provider Status”, publication, research, speaking and presentation nationally and internationally, manufacturer education and product consulting, insertion and supervision of PICC lines and other related intravenous devices.
Lynn Hadaway
Lynn HadawayM.Ed., RN-BC, CRNI
Lynn’s entire nursing career has been spent in the practice of intravenous infusion nursing and vascular access. For the past 18 years, her consulting company has provided consulting services to large and small manufacturers of devices and drugs. They provide provide continuing education courses in both traditional classroom settings and online.

Lynn’s goal is to improve the quality of care that is provided to patients receiving intravenous infusion therapy by improving the design of products we use and by educating all healthcare professionals about the principles, practices, and evidence associated with this specialty.

Specialties: Published author, infection prevention in infusion therapy, device design and its clinical application, market trends and analysis, training in new devices, sales training, design and development of continuing professional education, writing white papers, assisting new authors with publication process, internationally known speaker on infusion topics.


At Linear Health Sciences we’ve focused on making our concept become a reality.

By identifying the right partners the Orchid Safety Release Valve will be able to come to market faster and smarter vs. traditional processes. That all starts with the first partner and incubator channel: i2E.

i2E, inc.

With offices in Oklahoma City and Tulsa, OK, i2E’s nationally recognized services include business expertise and funding for Oklahoma’s emerging small businesses. i2E has nearly $50 million of investment capital under management.

i2E Innovation

Gilero has grown into a one-stop shop for the design, development and contract manufacturing of everything from consumable medical devices to complex electromechanical drug delivery systems. Gilero was conceived by three engineers who spent mornings, nights and weekends together brainstorming ideas for how they could use their product development skills and interest in medical devices to start their own company.

Gilero’s pedigree focuses on the medical device and drug delivery markets, offering services in design, development, regulatory, testing, tooling, molding and manufacturing of finished devices.


Founded in 2008, R&Q provides integrated quality and regulatory consulting solutions to medical device companies. We support the life-cycle of medical devices from conceptual development through post-market surveillance, providing solutions that accelerate the success of medical device companies and improve people’s lives. Business-focused with proven best practice, strategic, and tactical solutions, R&Q experts focus on all aspects of business-balanced decisions of regulatory and quality, emerging trends, and defining new ways of maintaining compliance. R&Q’s strategic problem solvers are keenly focused on our customer’s success.



The Global Center of Medical Innovation (GCMI), is the world’s leader in driving efficient medical product innovation. 

Using our proven high-quality processes, our expert staff serves Fortune 500, start-up, academic and government funded innovators. We work in over 11 therapeutic areas and a wide-array of medical products (Class I, II and III) including drugs and biologics. We are a fee-for-service provider with in-house expertise for successfully executing the medical product value-chain including the following service lines:

Phase Zero (P0)– Providing full life-cycle assessments for innovative medical products.

Design and Development (D2)– Good Manufacturing Practice(GMP)compliant designing and prototyping services for medical products, and “incubator” space for resident-clients.

Translational Testing and Training Labs, Inc. (T3 Labs) – Good Laboratory Practice(GLP)-compliant, AAALAC accredited preclinical contract research organization providing feasibility, safety and usability testing services to voice-of-customer and proof of concept events and physician/bioskills training in animate and cadaveric models.

Utilizing in-house resources, local core-lab resources and third-party service providers located around the world, GCMI works every day to commercialize innovative medical products that improve quality based outcomes and delivery of healthcare for patients.

GCMI, and its wholly owned subsidiary T3 Labs, is a non-profit 501(c)(3) and affiliate of the Georgia Institute of Technology, a member of the University System of Georgia. GCMI is also a member of the GA Bio and the Southeastern Medical Device Association (SEMDA).

Global Center for Medical Innovation


MedTech Innovator

Here at Linear Health Sciences we know a good thing when we see it. In association with Advamed, MedTech Innovator is the premier virtual accelerator in the Medtech space. Out of 430 applicants and over 90 advisors Linear Health Sciences is proud to be one of just 20 semi-finalists to be enrolled.

MedTech Innovator is the medtech industry’s global competition and virtual accelerator. Their mission is to accelerate the development of transformative innovations that benefit patients and deliver improved value to the health care system. Being associated with the program allows its semi-finalists to be exposed to key industry leaders, finance, and some of the world’s largest medical device manufacturers as
primary stakeholders and thought leaders while enrolled in the MedTech Innovator program.

Global Center for Medical Innovation

The Southeast’s first and only comprehensive medical device innovation center, dedicated to accelerating development, building businesses and improving health.

Global Center for Medical Innovation